Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing

Amy Murphy,Lala R. Hussain,Ching Ho,Erik M. Dunki-Jacobs,David E. Lee,Ashley Tameron,Karen Huelsman,Courtney Rice,Barbara Wexelman

Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing

2017

Amy Murphy
Lala R. Hussain
Ching Ho
Erik M. Dunki-Jacobs
David E. Lee
Ashley Tameron
Karen Huelsman
Courtney Rice
Barbara Wexelman

Background This study seeks to determine whether there is a delay in time to surgery in breast cancer patients with panel tests compared with traditional BRCA testing.

Keywords:

Breast cancer
Hereditary Cancer Syndromes
Surgery
Oncology
Medicine
Internal medicine
Genetic testing
Turnaround time
Mastectomy
Surgical oncology
impact time
Chemotherapy
Genetic counseling

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations